Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond

multichannel-pipette-loading-pcr-plate-with-angled-tips_adobestock_1712554696

Explore best practices for developing and validating qPCR assays that support vaccine and therapeutic clinical development.

This webinar examines the challenges of qPCR assay validation and the importance of harmonized analytical approaches across the bioanalytical industry. Learn how assay precision, sensitivity, extraction methods, and context of use influence assay performance, and discover practical strategies for generating reliable, regulatory-ready PCR data.

In this webinar, you'll learn:

  • The key challenges of developing and validating qPCR assays for vaccine and therapeutic studies
  • Best practices for evaluating assay precision, sensitivity, and context of use
  • How nucleic acid extraction methods can impact qPCR assay performance
  • Real-world case studies demonstrating assay optimization and validation strategies, including support for a Phase 3 COVID-19 vaccine clinical trial

As PCR continues to play a critical role in bioanalysis, robust validation strategies are essential for generating accurate, reproducible data. Discover practical approaches for optimizing qPCR assays while supporting regulatory expectations and successful clinical development.

Complete the form below to access this webinar.

Opportunities and Challenges of Developing and Validating qPCR Assays in Pivotal Vaccine Trials and Beyond

To learn more about how Eurofins processes and protects your personal data and your rights, please read our Privacy Notice.